tPA is the only Food and Drug Administration (FDA) approved treatment for stroke [6–9] that improves clinical function measured using either the National Institutes of Health Stroke (NIHSS) scale or modified Rankin scores (mRS)[10–13]. Here, PLAT is linked to stroke disorder.